Stingthera, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma (NCT04609579) | Stingthera, Inc. | 2020-11-18 |
Track Stingthera, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.